Skip to main content



Ethan Basch, MD Prostate, patient-reported outcomes, drug regulatory policy, comparative effectiveness
Lisa Carey, MD Breast Cancer; clinical/translational research in breast cancer including evaluation of novel drug combinations and clinical implications of molecular sub-typing
Cheryl Carlson, MD, PhD GI cancers
Marjory Charlot, MD, MPH Thoracic
Frances Collichio, MD Melanoma, Breast Cancer, Neuro-oncology and related Phase I/II studies; Associate Fellowship Director and Director for Fellowship Education
E. Claire Dees, MD Breast cancer and Phase I/development therapeutics
Matthew Foster, MD Hematologic Malignancies
Juneko Grilley-Olson, MD Head and neck cancer, lung cancer, sarcomas, developmental therapeutics, Phase I trials
Katarzyna Jamieson, MD Leukemia, Lymphoma and Myeloma Program, Bone marrow transplantation
Trevor Jolly, MBBS Geriatric Oncology, Geriatric Assessment of Older Cancer Patients
William Kim, MD GU cancer and basic investigations in hypoxia-inducible factor (HIF) in tumorigenesis
Carrie Lee, MD, MPH Melanoma, lung cancer, and Phase I clinical trials (novel anti-cancer agents).
Autumn McRee, MD GI cancer
Matthew Milowsky, MD GU malignancies
Shannon Morris, MD, PhD
Stergios Moschos, MD Melanoma
Hyman Muss, MD Breast cancer, geriatric oncology
Shetal Patel, MD, PhD Thoracic; head and neck
Emily Ray, MD, MPH Breast cancer
Katherine Reeder-Hayes, MD, MBA Breast cancer, health services research
Hanna Sanoff, MD, MPH GI, high risk populations, treatment-related toxicity
Jonathan Serody, MD Bone Marrow Transplant; dendritic cell vaccine in breast cancer, animal models of graft vs host disease and chemokine activation and regulation
Sid Sheth, MD Head and neck; thoracic
Hendrik van Deventer, MD Hematologic malignancies and laboratory investigations in the role of chemokines in the development of tumor metastases
Jared Weiss, MD Head and neck, thoracic malignancies
Young Whang, MD, PhD GU malignancies; laboratory-based studies examining aberrant signal transduction pathways and loss of tumor suppressor genes such as PTEN in carcinogenesis
William Wood, MD Hematologic malignancies, stem cell transplantation, health services